Prospective Evaluation of the Role of MRI in the Perioperative Management of Pancreas Adenocarcinomas
1 other identifier
interventional
50
1 country
1
Brief Summary
The precision of MRI has improved over the past few years, in particular for the hepatobiliary and pancreatic pathologies. The role of MRI in the management of operated pancreas tumors remains nevertheless unclear and few studies have compared MRI to the actual gold standard (CT). Compared to CT, MRI is not only a morphologic imaging technique but also a functional imaging technique. MRI could therefore evaluate in a non-ionizing and dynamic way several important pre- and postoperative aspects after pancreaticoduodenectomy (PD). This study on the perioperative role of MRI includes 3 parts: First, CT is known to minimize the real size of the pancreatic tumors and to underestimate the vascular invasion correlated to resectability. The preoperative determination of the resection surgical margins could be improved thanks to the high-contrast resolution of MRI. Moreover, PD is a complex surgery encompassing a fragile anastomosis between the pancreatic parenchyma and the digestive tract. The permeability of the pancreatic anastomosis after PD remains presently unknown and has not been correlated to the clinical state of the patient. MRI associated with secretin injection allows evaluating this permeability, which cannot be done by CT due to the absence of functional evaluation. Finally, present radiological follow-up after PD for tumors of the pancreatic head is performed with CT. The MRI performance has not been demonstrated yet in the context of follow-up. This imaging modality nevertheless offers unique specificities that are very interesting and that could be helpful for the diagnosis of recurrence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 5, 2016
CompletedFirst Posted
Study publicly available on registry
October 22, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedJune 11, 2020
June 1, 2020
3.9 years
August 5, 2016
June 10, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of the MRI precision in the delimitation of circumferential resection margins
The preoperative MRI results will be compared to the anatomopathological results.
Preoperative MRI performed up to one month before the operation date.
Secondary Outcomes (6)
Evaluation of the potential correlation between the tumor size and the resection margins.
Preoperative MRI performed up to one month before the operation date.
Determination of the pancreatic anastomosis permeability
One year after the operation
Determination of the rate of exocrine insufficiency
One year after the operation
Correlation between anastomosis non-permeability and exocrine insufficiency.
One year after the operation
Evaluation of a questionnaire for pancreas exocrine insufficiency
One year after the operation
- +1 more secondary outcomes
Study Arms (1)
Pre- and postoperative MRI
OTHERAll patients will undergo a preoperative MRI and will have a postoperative follow-up with CT and MRI.
Interventions
Eligibility Criteria
You may qualify if:
- patients over 18 years old
- indication for a PD for a resectable adenocarcinoma of the pancreatic head.
You may not qualify if:
- chronic pancreatitis
- absence of discernment
- patients not speaking French
- preoperative radio/chemotherapy
- patients with claustrophobia
- patients with metallic implants.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Lausanne Hospital
Lausanne, Canton of Vaud, 1010, Switzerland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 5, 2016
First Posted
October 22, 2018
Study Start
July 1, 2016
Primary Completion
June 1, 2020
Study Completion
June 1, 2020
Last Updated
June 11, 2020
Record last verified: 2020-06